JB Chemicals & Pharmaceuticals Ltd.

1662.00 +16.00 ▲1.0%

28 March 2024, 04:01:00 PM
Volume: 4,997

Company Profile

Sector Healthcare Sector Icon Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Industry Icon Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.jbpharma.com
Market Cap 25,598.61 Cr.
Enterprise Value(EV) 25,932.51 Cr. 2023-09
Financial Indicators
Earnings per share (EPS) 33.13 Trailing Twelve Months Ending 2023-12
Price-Earning Ratio (PE) 49.79 Trailing Twelve Months Ending 2023-12
Industry PE 41.54 Trailing Twelve Months Ending 2023-12
Book Value / Share 183.66 Trailing Twelve Months Ending 2023-12
Price to Book Value 8.98 Calculated using Price: 1,649.45
Dividend Yield 0.54 Period Ending 2023-03
No. of Shares Subscribed 15.52 Cr. 155,194,800 Shares
FaceValue 1
About JB Chemicals & Pharmaceuticals Ltd.
J. B. Chemicals & Pharmaceuticals is engaged in the business of manufacturing and marketing of diverse range of pharmaceutical formulations, herbal remedies and APIs. JBCPL is widely committed to manufacturing a range of innovative specialty products that include various pharmaceutical dosage forms like tablets, injectable (vials, ampoules, form fill seal), creams & ointments, lozenges, herbal liquids and capsules. In India and International markets, JBCPL is also known as Unique Pharmaceutical Laboratories and is a division of JBCPL.

JB Chemicals & Pharmaceuticals Ltd. Delivery

Delivered Qty
Traded Qty

JB Chemicals & Pharmaceuticals Ltd. Performance

1 Day
+0.97%
1 Week
+4.72%
1 Month
+1.08%
3 Month
+2.37%
6 Month
+17.69%
1 Year
+70.49%
2 Year
+112.19%
5 Year
+839.94%
10 Year
+2572.03%

JB Chemicals & Pharmaceuticals Ltd. Fundamental Ratios

9 years 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) 9.86 14.93 14.48 9.89 13.28 18.69 27.64 19.89 18.51
Return on Capital Employed (%) 13.49 17.83 16.87 13.7 19.59 23.71 36.53 25.48 22.79
Return on Assets (%) 7.08 9.29 8.99 6.43 8.52 12.53 19.55 13.69 11.44

JB Chemicals & Pharmaceuticals Ltd. Balance Sheet

Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09* Rs. Cr.
Shh. Funds 995 1,184 1,364 1,442 1,480 1,435 1,810 2,134 2,480 2,717
Non Curr. Liab. 33 31 27 46 65 63 72 475 992 434
Curr. Liab. 460 797 693 737 782 516 687 455 626 643
Minority Int. 2 2 3 3 3 4 4
Equity & Liab. 1,487 2,014 2,086 2,226 2,329 2,017 2,572 3,069 4,098 3,794
Non Curr. Assets 586 832 879 718 741 741 679 1,745 2,499 2,036
Curr. Assets 901 1,182 1,207 1,509 1,589 1,276 1,894 1,325 1,599 1,758
Misc. Exp. not W/O
Total Assets 1,487 2,014 2,086 2,226 2,329 2,017 2,572 3,069 4,098 3,794

JB Chemicals & Pharmaceuticals Ltd. Profit and Loss

Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-12 Rs. Cr. TTM
Net Sales 1,144 1,232 1,368 1,414 1,643 1,775 2,043 2,424 3,149 3,385
Other Income 11 57 54 55 41 51 117 40 10 25
Total Income 1,155 1,288 1,422 1,469 1,685 1,826 2,159 2,464 3,159 3,410
Total Expenditure -964 -1,026 -1,140 -1,215 -1,337 -1,397 -1,486 -1,882 -2,454 -2,522
PBIDT 191 263 283 254 347 428 673 583 706 888
Interest -7 -11 -5 -3 -5 -3 -7 -5 -36 -49
Depreciation -39 -41 -47 -57 -56 -66 -69 -73 -114 -129
Taxation -45 -50 -46 -55 -93 -77 -148 -119 -145 -195
Exceptional Items -10
PAT 100 163 184 139 194 272 449 386 410 514
Minority Interest 0 0 0 -1 0 -1 -1 0
Share Associate
Other Related Items
Consolidated Net Profit 100 163 184 138 193 272 448 385 410 514
Adjusted EPS 6 10 11 8 12 18 29 25 26 33

JB Chemicals & Pharmaceuticals Ltd. Cash Flow

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. -14 127 140 201 123 194 276 315 170 626
Cash Fr. Inv. -143 -112 -28 -45 -21 -28 24 -231 2 -962
Cash Fr. Finan. 12 -1 -100 -184 -60 -156 -306 -87 -138 357
Net Change -144 13 13 -28 43 11 -6 -3 34 20
Cash & Cash Eqvt 12 25 9 -21 21 32 26 22 57 77

JB Chemicals & Pharmaceuticals Ltd. Shareholding Pattern

9 Qtrs 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%) 2023-09 (%) 2023-12 (%)
Promoter 54.00 54.00 54.00 53.96 53.95 53.93 53.91 53.86 53.83
Public 46.00 46.00 46.00 46.04 46.05 46.07 46.09 46.14 46.17
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

JB Chemicals & Pharmaceuticals Ltd. Announcements

Wed, 27 Mar 2024
Closure of Trading Window
Intimation of Trading Window Closure period
Fri, 22 Mar 2024
Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015
Disclosure under Regulation 30 - Receipt of Order
Sat, 09 Mar 2024
Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper advertisement for Postal Ballot

JB Chemicals & Pharmaceuticals Ltd. Technical Scans

Thu, 28 Mar 2024
Close Crossing Last Week High Close Crossing Last Week High
Opening at Low Opening at Low
Close Within 52 Week High Zone Close Within 52 Week High Zone
Close Above Last Week High Close Above Last Week High
Making Higher Highs for 2 Days Making Higher Highs for 2 Days

JB Chemicals & Pharmaceuticals Ltd. Related Stocks

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 388,812.23 1,620.50 +0.8%
Cipla Ltd. 120,673.12 1,494.65 +1.9%
Dr. Reddy's Laboratories Ltd. 102,679.14 6,171.85 +2.0%
Zydus Lifesciences Ltd. 101,151.67 1,007.35 +0.8%
Mankind Pharma Ltd. 92,029.19 2,300.75 -1.5%
Apollo Hospitals Enterprise Ltd. 91,330.58 6,347.35 +1.9%
Divi's Laboratories Ltd. 91,234.91 3,452.55 +2.6%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 43.66 1,620.50 +0.8%
Cipla Ltd. Consolidated 2023-12 32.54 1,494.65 +1.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 19.64 6,171.85 +2.0%
Zydus Lifesciences Ltd. Consolidated 2023-12 34.01 1,007.35 +0.8%
Mankind Pharma Ltd. Consolidated 2023-12 53.29 2,300.75 -1.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 115.71 6,347.35 +1.9%
Divi's Laboratories Ltd. Consolidated 2023-12 65.97 3,452.55 +2.6%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 6.23 1,620.50 +0.8%
Cipla Ltd. Consolidated 2023-12 4.66 1,494.65 +1.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 3.82 6,171.85 +2.0%
Zydus Lifesciences Ltd. Consolidated 2023-12 5.37 1,007.35 +0.8%
Mankind Pharma Ltd. Consolidated 2023-12 10.36 2,300.75 -1.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 13.52 6,347.35 +1.9%
Divi's Laboratories Ltd. Consolidated 2023-12 7.00 3,452.55 +2.6%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,620.50 +0.8%
Cipla Ltd. Consolidated 2023-03 0.02 1,494.65 +1.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 6,171.85 +2.0%
Zydus Lifesciences Ltd. Consolidated 2023-03 0.07 1,007.35 +0.8%
Mankind Pharma Ltd. Consolidated 2023-03 0.02 2,300.75 -1.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 6,347.35 +1.9%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,452.55 +2.6%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,620.50 +0.8%
Cipla Ltd. Consolidated 2023-03 12.85 1,494.65 +1.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,171.85 +2.0%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 1,007.35 +0.8%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 2,300.75 -1.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,347.35 +1.9%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,452.55 +2.6%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,620.50 +0.8%
Cipla Ltd. Consolidated 2023-03 12.85 1,494.65 +1.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,171.85 +2.0%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 1,007.35 +0.8%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 2,300.75 -1.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,347.35 +1.9%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,452.55 +2.6%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,620.50 +0.8%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,494.65 +1.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 6,171.85 +2.0%
Zydus Lifesciences Ltd. Consolidated 2023-03 17,237.40 1,007.35 +0.8%
Mankind Pharma Ltd. Consolidated 2023-03 8,749.43 2,300.75 -1.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 6,347.35 +1.9%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,452.55 +2.6%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,620.50 +0.8%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,494.65 +1.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 6,171.85 +2.0%
Zydus Lifesciences Ltd. Consolidated 2023-03 2,001.90 1,007.35 +0.8%
Mankind Pharma Ltd. Consolidated 2023-03 1,309.68 2,300.75 -1.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 6,347.35 +1.9%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,452.55 +2.6%

JB Chemicals & Pharmaceuticals Ltd. FAQ's

What is JB Chem & Pharma share price?

Can I buy JB Chem & Pharma shares now?

What is the Dividend Yield of JB Chem & Pharma?

What is the Market Cap of JB Chem & Pharma?

What are the key metrics to analyse JB Chem & Pharma?

What is the 52 Week High and Low of JB Chem & Pharma?

What is the trend of JB Chem & Pharma share price?